MDT
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial.Reddy JP, Sherry AD, Fellman B, et al. Int J Radiat Oncol Biol Phys. 2025 Mar 15;12…
IPDMA - RADICAL - NSCLC: individual participant data meta-analysis and systematic review of radical local therapy for oligometastatic NSCLC.Tiwari K, Shamim MA, Yadav I, et al. BMJ Open Respir Res. 2025 Sep 17;12(1):e003276. doi: 10.1136/b…
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial.Tang C, Sherry AD, Seo A, et al. Lancet Oncol. 2025 Sep …
